Ruzinova, M. B., Lee, Y., Duncavage, E. J., & Welch, J. S. (2019). TP53 immunohistochemistry correlates with TP53 mutation status and clearance in decitabine-treated patients with myeloid malignancies. Haematologica.
Style de citation ChicagoRuzinova, Marianna B., Yi-Shan Lee, Eric J. Duncavage, et John S. Welch. "TP53 Immunohistochemistry Correlates With TP53 Mutation Status and Clearance in Decitabine-treated Patients With Myeloid Malignancies." Haematologica 2019.
Style de citation MLARuzinova, Marianna B., Yi-Shan Lee, Eric J. Duncavage, et John S. Welch. "TP53 Immunohistochemistry Correlates With TP53 Mutation Status and Clearance in Decitabine-treated Patients With Myeloid Malignancies." Haematologica 2019.
Attention : ces citations peuvent ne pas être correctes à 100%.